Impact of concomitant aortic valve replacement in patients with mild‐to‐moderate aortic valve regurgitation undergoing left ventricular assist device implantation: EUROMACS analysis
Artificial Organs · 2025-04 · 49 (4) · 691-704
DOI: 10.1111/aor.14926 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 10.12.2024. Verfasst von Gregorio Gliozzi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Surgery Unit, Cardiothoracic Department, University Hospital of Udine, Udine, Italy. Hauptthemen laut MEDLINE: Heart-Assist Devices, Aortic Valve Insufficiency, Heart Valve Prosthesis Implantation, Aortic Valve. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Left ventricular assist device (LVAD) therapy may lead to an aortic regurgitation, limiting left ventricular unloading and causing adverse events. Whether concomitant aortic valve replacement may improve outcomes in patients with preoperative mild‐to‐moderate aortic regurgitation remains unclear.
Methods
A retrospective propensity score‐matched analysis of adult patients with preoperative mild‐to‐moderate aortic regurgitation undergoing durable LVAD implantation between 01/01/2011 and 30/11/2021 was performed. Patients undergoing concomitant valve surgery other than biological aortic valve replacement were excluded, resulting in 77 with concomitant biological aortic valve replacement and 385 without.
Results
Following 1:1 propensity score matching, two groups of 55 patients with and without biological aortic valve replacement were obtained, (mean age 59 ± 11 years, 92% male, 59.1% HeartWare). Aortic regurgitation was mild in 72.7% and 76.4% and moderate in 27.3% and 23.6% in non‐replacement and replacement cohorts respectively. The 30‐day survival was 89.1% vs. 85.5% ( p = 0.59), 1‐year survival 69.1% vs. 56.4% ( p = 0.19), and 2‐year survival 61.8% vs. 47.3% ( p = 0.10) in the non‐replacement and replacement groups, respectively. After a mean follow‐up of 1.2 years, non‐replacement patients had a higher incidence of pump thrombosis (11 [20%] vs. 3 [5.5%], p = 0.022) and fewer major bleedings (2 [3.6%] vs. 11 [20%], p = 0.008).
Conclusion
Compared with those treated conservatively, patients with mild‐to‐moderate aortic regurgitation undergoing concomitant aortic valve replacement during LVAD implantation have a similar survival up to 2 years on support. Patients with concomitant valve replacement had a higher risk of bleeding complications but fewer pump thromboses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiac Surgery Unit, Cardiothoracic Department, University Hospital of Udine, Udine, Italy.
- Department of Medical and Surgical Sciences (DIMES), Alma Mater Studiorum - University of Bologna, Bologna, Italy.
- Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany.
- DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
- City of Health and Science Hospital Turin, Department of Surgical Sciences, University of Turin, Turin, Italy.
- Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
ORCID-Profile: Gaik Nersesian, Guglielmo Gallone, Theo M M H de By, Gloria Faerber, Antonio Spitaleri, Antonio Loforte
Zitieren
APA
Gliozzi, G., Nersesian, G., Gallone, G., Schoenrath, F., Netuka, I., Zimpfer, D., de By, T. M. M. H., Faerber, G., Spitaleri, A., Vendramin, I., Gummert, J., Falk, V., Meyns, B., Rinaldi, M., Potapov, E., & Loforte, A. (2025). Impact of concomitant aortic valve replacement in patients with mild‐to‐moderate aortic valve regurgitation undergoing left ventricular assist device implantation: EUROMACS analysis. Artificial Organs, 49(4), 691-704. https://doi.org/10.1111/aor.14926
Vancouver
Gliozzi G, Nersesian G, Gallone G, Schoenrath F, Netuka I, Zimpfer D, et al. Impact of concomitant aortic valve replacement in patients with mild‐to‐moderate aortic valve regurgitation undergoing left ventricular assist device implantation: EUROMACS analysis. Artificial Organs. 2025;49(4):691-704. doi:10.1111/aor.14926
BibTeX
@article{Gliozzi2025,
author = {Gliozzi, Gregorio and Nersesian, Gaik and Gallone, Guglielmo and Schoenrath, Felix and Netuka, Ivan and Zimpfer, Daniel and de By, Theo M M H and Faerber, Gloria and Spitaleri, Antonio and Vendramin, Igor and Gummert, Jan and Falk, Volkmar and Meyns, Bart and Rinaldi, Mauro and Potapov, Evgenij and Loforte, Antonio},
title = {Impact of concomitant aortic valve replacement in patients with mild‐to‐moderate aortic valve regurgitation undergoing left ventricular assist device implantation: EUROMACS analysis},
journal = {Artificial Organs},
year = {2025},
volume = {49},
number = {4},
pages = {691--704},
doi = {10.1111/aor.14926}
}
EUVIMED